- Home
- MYGN vs HLX Comparison
MYGN vs HLX Comparison
Compare MYGN & HLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYGN
- HLX
- Stock Information
- Founded
- MYGN 1991
- HLX 1979
- Country
- MYGN United States
- HLX United States
- Employees
- MYGN N/A
- HLX N/A
- Industry
- MYGN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- HLX Oilfield Services/Equipment
- Sector
- MYGN Health Care
- HLX Energy
- Exchange
- MYGN Nasdaq
- HLX Nasdaq
- Market Cap
- MYGN 2.0B
- HLX 1.7B
- IPO Year
- MYGN 1995
- HLX 1997
- Fundamental
- Price
- MYGN $13.36
- HLX $9.08
- Analyst Decision
- MYGN Hold
- HLX Strong Buy
- Analyst Count
- MYGN 12
- HLX 4
- Target Price
- MYGN $23.92
- HLX $13.33
- AVG Volume (30 Days)
- MYGN 942.4K
- HLX 1.2M
- Earning Date
- MYGN 11-07-2024
- HLX 10-23-2024
- Dividend Yield
- MYGN N/A
- HLX N/A
- EPS Growth
- MYGN N/A
- HLX N/A
- EPS
- MYGN N/A
- HLX 0.05
- Revenue
- MYGN $823,600,000.00
- HLX $1,338,584,000.00
- Revenue This Year
- MYGN $13.82
- HLX $3.12
- Revenue Next Year
- MYGN $4.59
- HLX $4.96
- P/E Ratio
- MYGN N/A
- HLX $192.12
- Revenue Growth
- MYGN 12.15
- HLX 7.74
- 52 Week Low
- MYGN $12.87
- HLX $8.81
- 52 Week High
- MYGN $29.30
- HLX $13.05
- Technical
- Relative Strength Index (RSI)
- MYGN 26.22
- HLX 32.98
- Support Level
- MYGN $12.87
- HLX $9.72
- Resistance Level
- MYGN $15.44
- HLX $9.49
- Average True Range (ATR)
- MYGN 0.84
- HLX 0.37
- MACD
- MYGN -0.02
- HLX -0.15
- Stochastic Oscillator
- MYGN 12.37
- HLX 12.39
About MYGN Myriad Genetics Inc.
Myriad Genetics is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel with the capability to identify the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm offers biomarker discovery and companion diagnostic services to pharma and biotech companies.
About HLX Helix Energy Solutions Group Inc.
Helix Energy Solutions Group Inc is an offshore energy services company. It provides specialty services to the offshore energy industry, with an emphasis on well intervention and robotics operations. Helix provides services in deep water in the Gulf of Mexico, Brazil, the North Sea, Asia Pacific and West Africa regions. It has four segments Well Intervention, Robotics, Production Facilities and Shallow Water Abandonment. the Well Intervention segment includes vessels and equipment used to perform well intervention services in the Gulf of Mexico, the North Sea and Brazil. It derives the majority of its revenue from the US.